The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.
Search or browse funded studies
Previously funded studies appear chronologically, with the most recent appearing first.
-
ASAP CRN Discovery Fellowship 2025, 2026Can Alpha Synuclein Move Between Neurons?
Study Rationale:
Alpha synuclein is a protein that accumulates inside neurons in Parkinson’s disease. A lot of research has assume,d but never fully prove,n that this protein…
-
ASAP CRN Discovery Fellowship 2025, 2026Causal Mapping of Enhancer-Gene Networks in Parkinson’s Disease via Single-Cell Perturb-Seq and AI
Study Rationale:
Most of our DNA does not contain genes but instead acts like a complex switchboard that controls when and where genes are turned on or off. In Parkinson’s…
-
ASAP CRN Discovery Fellowship 2025, 2026Network Control of Neuronal Resilience in Parkinson’s Disease
Study Rationale:
In Parkinson’s disease, damage caused by disease processes leads to the death of certain brain cells, but not all cells are equally affected. Some are more…
-
ASAP CRN Discovery Fellowship 2025, 2026The Pathogenic Role of Neuronal DNA-Sensing cGAS–STING Pathway in Alpha-Synucleinopathy
Study Rationale:
Parkinson’s Disease (PD) is characterized by neuronal aggregation of toxic alpha-synuclein (aS) protein and subsequent loss of neurons. My research found that…
-
ASAP CRN Discovery Fellowship 2025, 2026Unravelling the Impact of the Microbiome on Motor Dysfunction in Parkinson’s Disease Using Phenotypic Heterogeneity in the Pink1-/- Infection-Induced Disease Model
Study Rationale:
Development of Parkinson’s Disease (PD) involves genetic and environmental factors. Not all people with genetic risk factors for PD develop the disease…
-
Research Grant, 2026Automated Platform for Standardizing and Validating GBA1 Human iPSC Models To Accelerate Mechanistic and Therapeutic Discovery in Parkinson’s Disease
Study Rationale: Mutations in the GBA1 gene are the most common known genetic risk factors for Parkinson’s disease (PD). Individuals who carry these mutations not only have an increased risk of…
Apply for a Grant
Our funding programs support basic, translational and clinical research from academia and industry.